10 related articles for article (PubMed ID: 38719675)
1. Outcome predictors for patients with stage II/III gastric cancer who undergo gastrectomy and S-1 adjuvant chemotherapy.
Fujiwara Y; Fukuda S; Tsujie M; Kitani K; Inoue K; Hayashi T; Ishikawa H; Yukawa M; Inoue M
Oncol Lett; 2017 Aug; 14(2):1621-1627. PubMed ID: 28789388
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemotherapy, p53, carcinoembryonic antigen expression and prognosis after D2 gastrectomy for gastric adenocarcinoma.
He MM; Zhang DS; Wang F; Wang ZQ; Luo HY; Ren C; Jin Y; Chen DL; Xu RH
World J Gastroenterol; 2014 Jan; 20(1):264-73. PubMed ID: 24415881
[TBL] [Abstract][Full Text] [Related]
3. Surgery alone, adjuvant tegafur/gimeracil/octeracil (S-1), or platinum-based chemotherapies for resectable gastric cancer: real-world experience and a propensity score matching analysis.
Yen CC; Shan YS; Chao YJ; Liao TK; Chen IS; Huang HY; Liu IT; Yen CJ
BMC Cancer; 2021 Jul; 21(1):796. PubMed ID: 34243732
[TBL] [Abstract][Full Text] [Related]
4. The association between the duration of fluoropyrimidine-based adjuvant chemotherapy and survival in stage II or III gastric cancer.
Kim SG; Hwang SH
World J Surg Oncol; 2016 Apr; 14():102. PubMed ID: 27039375
[TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of adjuvant chemotherapy for curatively resected gastric cancer.
Deng W; Wang QW; Zhang XT; Lu M; Li J; Li Y; Gong JF; Zhou J; Lu ZH; Shen L
World J Gastroenterol; 2014 Mar; 20(12):3356-63. PubMed ID: 24696615
[TBL] [Abstract][Full Text] [Related]
6. Long-term Efficacy of S-1 Monotherapy or Capecitabine Plus Oxaliplatin as Adjuvant Chemotherapy for Patients with Stage II or III Gastric Cancer after Curative Gastrectomy: a Propensity Score-Matched Multicenter Cohort Study.
Lee CM; Yoo MW; Son YG; Oh SJ; Kim JH; Kim HI; Park JM; Hur H; Jee YS; Hwang SH; Jin SH; Lee SE; Park JH; Seo KW; Park S; Kim CH; Jeong IH; Lee HH; Choi SI; Lee SI; Kim CY; Kim IH; Son MW; Pak KH; Kim S; Lee MS; Min JS
J Gastric Cancer; 2020 Jun; 20(2):152-164. PubMed ID: 32595999
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy for stage II and III gastric adenocarcinoma: A retrospective analysis with long-term follow-up.
Wang HT; Chiu CF; Yang HR; Jeng LB; Bai EJ; Chen TH; Yeh CC; Chu CL; Bai LY
J Formos Med Assoc; 2024 May; ():. PubMed ID: 38719675
[TBL] [Abstract][Full Text] [Related]
8.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
